Letters
Oseltamivir and zanamivir for flu
Department of Health’s misguided alert recommending neuraminidase inhibitors for flu
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1594 (Published 19 February 2014) Cite this as: BMJ 2014;348:g1594- Patricia McGettigan, clinical pharmacologist1,
- Allyson Pollock, professor2,
- Andrew Herxheimer, emeritus fellow, Cochrane Collaboration3
- 1William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London EC1M 6BQ, UK
- 2Global Health, Policy and Innovation Unit, Queen Mary, University of London, UK
- 3London, UK
- p.mcgettigan{at}qmul.ac.uk
On 27 January 2014, the Department of Health’s chief medical and pharmaceutical officers, Sally Davies and Keith Ridge, wrote a “for action” alert to NHS England leads, GPs, and community pharmacies endorsing the use of the antiviral drugs oseltamivir and zanamivir for prophylaxis and treatment of flu.1 2 The alert authorises GPs to prescribe the drugs at NHS expense for …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.